Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 15 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Pectasides, D  [Clear All Filters]
2014
Koutras, A. K., Kotoula V., Papadimitriou C., Dionysopoulos D., Zagouri F., Kalofonos H. P., et al. (2014).  Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel.. Pharmacogenomics J. 14(3), 248-55.
2013
Pliarchopoulou, K., Kalogeras K. T., Kronenwett R., Wirtz R. M., Eleftheraki A. G., Batistatou A., et al. (2013).  Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.. Cancer Chemother Pharmacol. 71(1), 245-55.
Bamias, A., Dafni U., Karadimou A., Timotheadou E., Aravantinos G., Psyrri A., et al. (2013).  Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).. Ann Oncol. 24(4), 1011-7.
2012
Psyrri, A., Kalogeras K. T., Kronenwett R., Wirtz R. M., Batistatou A., Bournakis E., et al. (2012).  Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study.. Ann Oncol. 23(6), 1422-7.
Skarlos, P., Christodoulou C., Kalogeras K. T., Eleftheraki A. G., Bobos M., Batistatou A., et al. (2012).  Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.. Cancer Chemother Pharmacol. 69(2), 533-46.
Koutras, A. K., Antonacopoulou A. G., Eleftheraki A. G., Dimitrakopoulos F-I., Koumarianou A., Varthalitis I., et al. (2012).  Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab.. Pharmacogenomics J. 12(6), 468-75.
2011
Razis, E., Bobos M., Kotoula V., Eleftheraki A. G., Kalofonos H. P., Pavlakis K., et al. (2011).  Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.. Breast Cancer Res Treat. 128(2), 447-56.
Kosmidis, P. A., Fountzilas G., Eleftheraki A. G., Kalofonos H. P., Pentheroudakis G., Skarlos D., et al. (2011).  Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).. Ann Oncol. 22(4), 827-34.
2010
Ihnen, M., Wirtz R. M., Kalogeras K. T., Milde-Langosch K., Schmidt M., Witzel I., et al. (2010).  Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.. Br J Cancer. 103(7), 1048-56.
Bamias, A., Karina M., Papakostas P., Kostopoulos I., Bobos M., Vourli G., et al. (2010).  A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer.. Cancer Chemother Pharmacol. 65(6), 1009-21.
2009
Pectasides, D., Papaxoinis G., Nikolaou M., Valavanis C., Aravantinos G., Fountzilas G., et al. (2009).  Analysis of 7 immunohistochemical markers in male germ cell tumors demonstrates the prognostic significance of p53 and MIB-1.. Anticancer Res. 29(2), 737-44.
Pectasides, D., Papaxoinis G., Fountzilas G., Aravantinos G., Bamias A., Pavlidis N., et al. (2009).  Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).. Anticancer Res. 29(2), 745-51.
Koumarianou, A., Fountzilas G., Kosmidis P., Klouvas G., Samantas E., Kalofonos C., et al. (2009).  Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patients.. J Chemother. 21(5), 573-83.
Pectasides, D., Pectasides E., Papaxoinis G., Andreadis C., Papatsibas G., Fountzilas G., et al. (2009).  Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients.. Gynecol Oncol. 115(1), 97-101.
Fountzilas, G., Dafni U., Dimopoulos M. A., Koutras A., Skarlos D., Papakostas P., et al. (2009).  A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study.. Breast Cancer Res Treat. 115(1), 87-99.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές